Tower Research Capital LLC (Trc) Orgenesis Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.39 - $0.63 $246 - $397	631 New	631 $0
Q2 2023 Aug 14, 2023	SELL	$1.01 - $1.44 $10,700 - $15,256	-10,595 Reduced 83.09%	2,156 $2,000
Q1 2023 May 09, 2023	BUY	$1.18 - $2.59 $1,130 - $2,481	958 Added 8.12%	12,751 $15,000
Q4 2022 Feb 10, 2023	BUY	$1.18 - $2.24 $2,476 - $4,701	2,099 Added 21.65%	11,793 $23,000
Q3 2022 Nov 10, 2022	BUY	$1.38 - $2.38 $13,092 - $22,579	9,487 Added 4583.09%	9,694 $14,000
Q2 2022 Aug 15, 2022	BUY	$1.8 - $3.74 $250 - $519	139 Added 204.41%	207 $1,000
Q1 2022 May 12, 2022	SELL	$2.31 - $3.72 $3,689 - $5,940	-1,597 Reduced 95.92%	68 $0
Q4 2021 Feb 14, 2022	BUY	$2.61 - $4.9 $3,061 - $5,747	1,173 Added 238.41%	1,665 $5,000
Q3 2021 Nov 15, 2021	SELL	$4.6 - $5.44 $12,695 - $15,014	-2,760 Reduced 84.87%	492 $2,000
Q2 2021 Aug 16, 2021	SELL	$4.19 - $5.88 $12,549 - $17,610	-2,995 Reduced 47.94%	3,252 $16,000
Q1 2021 May 17, 2021	SELL	$4.77 - $8.08 $12,454 - $21,096	-2,611 Reduced 29.48%	6,247 $36,000
Q4 2020 Feb 16, 2021	SELL	$4.4 - $5.63 $36,190 - $46,306	-8,225 Reduced 48.15%	8,858 $40,000
Q3 2020 Nov 16, 2020	BUY	$4.75 - $5.99 $76,888 - $96,960	16,187 Added 1806.58%	17,083 $86,000
Q2 2020 Aug 13, 2020	BUY	$3.6 - $7.84 $3,225 - $7,024	896 New	896 $5,000
Q4 2019 Feb 07, 2020	SELL	$2.6 - $4.66 $260 - $466	-100 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$4.18 - $4.85 $418 - $484	100 New	100 $0
Q2 2019 Aug 13, 2019	SELL	$3.86 - $5.2 $2,895 - $3,900	-750 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$4.28 - $5.6 $3,210 - $4,200	750 New	750 $4,000
Q4 2018 Feb 14, 2019	SELL	$3.88 - $7.46 $2,071 - $3,983	-534 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.3 - $8.66 $2,830 - $4,624	534 New	534 $3,000

Others Institutions Holding ORGS

# of Institutions

Shares Held

134K

Call Options Held

Put Options Held

View Full List

About Orgenesis Inc.

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

More about ORGS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account